Latest Breaking News On - Chezy barenholz - Page 5 : comparemela.com

Former Dexcel Pharma Analytical Chemist to Join Innocan Pharma LPT Pharmaceutical R&D Team as it is Moving Forward with the LPT Development

Innocan Pharma Corporation: Innocan Reports Positive Results from Recent Preclinical Trial on Epileptic Seizures On a Dog using LPT: Since The Last LPT injection, Paco (dog) Has Not Had a Seizure for Over 10 weeks

Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - July 6, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce positive results

Innocan Pharma Corporation: Innocan Reports Successful Preclinical Dog-Trial Results Regarding Pain Management: It Was as If a New Dog Came into Our Lives

Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - June 24, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce successful

Innocan Reports Successful Preliminary Trial Results Regarding Epilepsy in Dogs

Innocan Pharma Corporation: Innocan Reports Successful Preliminary Trial Results Regarding Epilepsy in Dogs

Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - June 10, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce the successful